Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-08-18 9:55 pm Sale | 2025-07-29 | 13D | OS Therapies Incorporated OSTX | Shalom Auerbach | 2,677,570 8.500% | -10,000 (-0.37%) | Filing History |
| 2025-08-13 4:05 pm Purchase | 2025-06-30 | 13G | OS Therapies Incorporated OSTX | Thomas A. Satterfield, Jr. | 3,115,681 9.400% | 1,848,216 (+145.82%) | Filing History |
| 2025-05-09 9:30 pm Sale | 2025-05-07 | 13D | OS Therapies Incorporated OSTX | Shalom Auerbach | 2,687,570 9.900% | -142,012 (-5.02%) | Filing History |
| 2025-04-16 2:51 pm Purchase | 2025-04-09 | 13G | OS Therapies Incorporated OSTX | Ayala Pharmaceuticals Inc. ADXS | 2,164,215 9.990% | 2,164,215 (New Position) | Filing History |
| 2025-03-12 4:30 pm Unchanged | 2024-07-31 | 13D | OS Therapies Incorporated OSTX | Shalom Auerbach | 2,829,582 12.900% | 0 (Unchanged) | Filing History |
| 2025-02-28 4:05 pm Purchase | 2025-02-27 | 13D | OS Therapies Incorporated OSTX | Shalom Auerbach | 2,829,582 12.900% | 275,000 (+10.76%) | Filing History |
| 2025-02-12 08:02 am Sale | 2024-12-31 | 13G | OS Therapies Incorporated OSTX | Thomas A. Satterfield, Jr. | 1,267,465 5.900% | -27,524 (-2.13%) | Filing History |
| 2025-01-17 7:47 pm Purchase | 2024-07-31 | 13D | OS Therapies Incorporated OSTX | Shalom Auerbach | 2,554,582 11.900% | 2,554,582 (New Position) | Filing History |
| 2024-08-28 4:30 pm Purchase | 2024-08-02 | 13G | OS Therapies Incorporated OSTX | Thomas A. Satterfield, Jr. | 1,294,989 6.200% | 1,294,989 (New Position) | Filing History |